pn-152,243
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
3
Phase 4
0
Earliest trial started Dec 1, 1999 (NCT00037791)
Timeline
1990s
- Jan 1, 1999
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pn-152,243
- pn-196,444
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00038311 | Phase 3 | Sep 1, 2000 | Pfizer |
| NCT00039910 | Phase 3 | Jul 1, 2000 | Pfizer |
| NCT00037791 | Phase 3 | Dec 1, 1999 | Pfizer |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 3 | 3 | 1 | 1999 |
1 organizations
Page 1 / 1